نتائج البحث - "Zvonko, Milicevic"

1

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial

المؤلفون: Shweta, Urva, Tamer, Coskun, Mei Teng, Loh, Yu, Du, Melissa K, Thomas, Sirel, Gurbuz, Axel, Haupt, Charles T, Benson, Martha, Hernandez-Illas, David A, D'Alessio, Zvonko, Milicevic

المصدر: The Lancet. 400:1869-1881

مصطلحات موضوعية: Adult, Body Weight, Gastric Inhibitory Polypeptide, General Medicine, Middle Aged, Glucagon, Glucagon-Like Peptide-1 Receptor, Young Adult, Glucose, Diabetes Mellitus, Type 2, Double-Blind Method, Glucagon-Like Peptide 1, Receptors, Glucagon, Humans, Obesity, Aged

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6fbf9575e306306e92cc4c2bbb96b7Test
https://doi.org/10.1016/s0140-6736Test(22)02033-5

2

Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial

المؤلفون: Tim, Heise, Andrea, Mari, J Hans, DeVries, Shweta, Urva, Jing, Li, Edward John, Pratt, Tamer, Coskun, Melissa K, Thomas, Kieren J, Mather, Axel, Haupt, Zvonko, Milicevic

المساهمون: General Internal Medicine, APH - Health Behaviors & Chronic Diseases, Amsterdam Gastroenterology Endocrinology Metabolism

المصدر: Lancet. Diabetes and endocrinology, 10(6), 418-429. Elsevier BV

مصطلحات موضوعية: Adult, Blood Glucose, Glycated Hemoglobin, Endocrinology, Diabetes and Metabolism, Glucagon-Like Peptides, Insulins, Gastric Inhibitory Polypeptide, Glucagon, Glucagon-Like Peptide-1 Receptor, Islets of Langerhans, Treatment Outcome, Endocrinology, Diabetes Mellitus, Type 2, Double-Blind Method, Internal Medicine, Humans, Hypoglycemic Agents, Insulin Resistance

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::114333746341eaa7eb406318786f093dTest
https://pure.amc.nl/en/publications/effects-of-subcutaneous-tirzepatide-versus-placebo-or-semaglutide-on-pancreatic-islet-function-and-insulin-sensitivity-in-adults-with-type-2-diabetesTest(7eebb311-02b1-40db-b66f-d99628ecb9b1).html

3

Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes

المؤلفون: Ross Bray, Amir Nikooienejad, Deborah A. Robins, Axel Haupt, Kevin L. Duffin, Jonathan M. Wilson, Melissa K. Thomas, Zvonko Milicevic, Xuewei Cui

المصدر: The Journal of Clinical Endocrinology and Metabolism

مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Clinical Biochemistry, Type 2 diabetes, Biochemistry, Endocrinology, Insulin-Secreting Cells, Medicine, Proinsulin, GIP, Middle Aged, Prognosis, Homeostatic model assessment, Female, type 2 diabetes, AcademicSubjects/MED00250, medicine.drug, Adult, medicine.medical_specialty, Adolescent, tirzepatide, Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 Receptor, Young Adult, Insulin resistance, Clinical Trials, Phase II as Topic, Internal medicine, insulin sensitivity, Humans, Hypoglycemic Agents, Glucagon-like peptide 1 receptor, Clinical Research Articles, Aged, Glycated Hemoglobin, Adiponectin, business.industry, beta-cell function, Insulin, Biochemistry (medical), medicine.disease, Diabetes Mellitus, Type 2, Dulaglutide, Insulin Resistance, business, GLP-1, Biomarkers, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6320a46b48d64dfafd5061c85da73165Test
http://europepmc.org/articles/PMC7823251Test

4

Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo‐controlled trial in patients with type 2 diabetes using metformin

المؤلفون: Lai S. Tham, Ying G. Li, Dagmar Bartaskova, Zvonko Milicevic, Brad Woodward, David A. Cox, Juan P. Frias, Alan G. Wynne, Beata Matyjaszek-Matuszek

المصدر: Diabetes, Obesity and Metabolism. 21:2048-2057

مصطلحات موضوعية: Adult, Blood Glucose, Male, medicine.medical_specialty, Nausea, Recombinant Fusion Proteins, Endocrinology, Diabetes and Metabolism, Glucagon-Like Peptides, Urology, Placebo-controlled study, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Placebo, 03 medical and health sciences, Subcutaneous injection, 0302 clinical medicine, Endocrinology, Double-Blind Method, Weight loss, Weight Loss, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Aged, Glycated Hemoglobin, business.industry, Middle Aged, medicine.disease, Metformin, Immunoglobulin Fc Fragments, Treatment Outcome, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Female, Dulaglutide, medicine.symptom, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bbb56e6e05c0c6bbde72032bfb9c14cTest
https://doi.org/10.1111/dom.13764Test

5

Factors Associated With Cardiovascular Events in Patients With Type 2 Diabetes and Acute Myocardial Infarction

المؤلفون: Scott J. Jacober, György Jermendy, Zvonko Milicevic, Itamar Raz, Anselm K. Gitt, Krzysztof Strojek, Rong Liu, Qianyi Zhang

المصدر: The Journal of Clinical Endocrinology & Metabolism. 101:243-253

مصطلحات موضوعية: Adult, Blood Glucose, Male, Acute coronary syndrome, medicine.medical_specialty, Endpoint Determination, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Myocardial Infarction, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Biochemistry, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Risk Factors, Diabetes mellitus, Internal medicine, Myocardial Revascularization, medicine, Humans, Myocardial infarction, Acute Coronary Syndrome, Stroke, Aged, Glycemic, Aged, 80 and over, Glycated Hemoglobin, business.industry, Biochemistry (medical), Type 2 Diabetes Mellitus, Middle Aged, medicine.disease, Survival Analysis, Surgery, Hospitalization, Treatment Outcome, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Myocardial infarction complications, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86ab46f958a9452af373ce0c761354afTest
https://doi.org/10.1210/jc.2015-1962Test

6

Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study

المؤلفون: Lawrence Blonde, Honghua Jiang, Jessie L. Fahrbach, Zvonko Milicevic, Jorge Luiz Gross, Vincent Woo, Johan Jendle

المصدر: The Lancet. 385:2057-2066

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Recombinant Fusion Proteins, medicine.medical_treatment, Glucagon-Like Peptides, Insulin Glargine, Type 2 diabetes, Bedtime, Drug Administration Schedule, law.invention, Young Adult, Randomized controlled trial, law, Internal medicine, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Aged, Glycated Hemoglobin, Insulin Lispro, Intention-to-treat analysis, Insulin glargine, business.industry, Insulin, General Medicine, Middle Aged, Postprandial Period, medicine.disease, Immunoglobulin Fc Fragments, Surgery, Insulin, Long-Acting, Treatment Outcome, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Female, Dulaglutide, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db9ae694e7f70fa658ac922998e28665Test
https://doi.org/10.1016/s0140-6736Test(15)60936-9

7

Response to the comment on: 'Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 trials'

المؤلفون: Sudha S. Shankar, Zvonko Milicevic, Jeremie Lebrec, Anne L. Peters, Sherry Martin, Raffaella Buzzetti, Paolo Pozzilli, Richard David Leslie, Imre Pavo, Nanette C. Schloot

المصدر: Diabetes, Obesity and Metabolism. 20:2319-2320

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eba57e1e2369f71adc817c7cb508fb4Test
https://doi.org/10.1111/dom.13366Test

8

Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes

المؤلفون: Andrea Mari, Chrisanthi A. Karanikas, Bernhard Ludvik, V. Pechtner, Zvonko Milicevic, L. Shurzinske, A. de la Peña, S. Del Prato

المصدر: Diabetes, obesitymetabolism. 18(8)

مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Glucagon-Like Peptides, Type 2 diabetes, 030204 cardiovascular system & hematology, Pharmacology, 0302 clinical medicine, Endocrinology, Insulin-Secreting Cells, Insulin, C-Peptide, digestive, oral, and skin physiology, Fasting, Middle Aged, β cells, Postprandial Period, Metformin, Diabetes and Metabolism, Postprandial, Treatment Outcome, Area Under Curve, Female, type 2 diabetes, dulaglutide, GLP-1 receptor agonists, metformin, Internal Medicine, medicine.drug, Adult, medicine.medical_specialty, Recombinant Fusion Proteins, 030209 endocrinology & metabolism, Glucagon, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Insulin resistance, Internal medicine, medicine, Humans, Hypoglycemic Agents, Glucagon-like peptide 1 receptor, Aged, Glycated Hemoglobin, business.industry, medicine.disease, Immunoglobulin Fc Fragments, Diabetes Mellitus, Type 2, Dulaglutide, Insulin Resistance, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76dbbbe56150202ea0e7ad16673b9b6aTest
https://pubmed.ncbi.nlm.nih.gov/27059816Test

9

Therapy after single oral agent failure: adding a second oral agent or an insulin mixture?

المؤلفون: Andrew S. Howard, James Malone, Scott D. Beattie, Zvonko Milicevic, Patricia A. Johnson, Barbara N. Campaigne

المصدر: Diabetes Research and Clinical Practice. 62:187-195

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ccd660bf894da0697602068d981aa62Test
https://doi.org/10.1016/j.diabres.2003.08.003Test

10

Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)

المؤلفون: Zvonko Milicevic, Jenny Y. Chien, Michael Heathman, T. Forst, James H. Anderson, Mary Jane Geiger, Donald Berry, Brenda Gaydos, Scott M. Berry, Zachary Skrivanek

المصدر: Diabetes, obesitymetabolism. 16(8)

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Randomization, Adolescent, Diet, Reducing, Endocrinology, Diabetes and Metabolism, Injections, Subcutaneous, Recombinant Fusion Proteins, Urology, Glucagon-Like Peptides, Type 2 diabetes, Placebo, Glucagon-Like Peptide-1 Receptor, law.invention, Young Adult, Endocrinology, Randomized controlled trial, law, Diet, Diabetic, Internal Medicine, Receptors, Glucagon, Medicine, Humans, Hypoglycemic Agents, Exercise, Aged, Dose-Response Relationship, Drug, business.industry, Middle Aged, Overweight, medicine.disease, Combined Modality Therapy, Metformin, Surgery, Immunoglobulin Fc Fragments, Blood pressure, Diabetes Mellitus, Type 2, Sitagliptin, Hyperglycemia, Dulaglutide, Drug Therapy, Combination, Female, Anti-Obesity Agents, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::709e199161463c62ec1afca80e875868Test
https://pubmed.ncbi.nlm.nih.gov/24762094Test

تنقيح النتائج